Home » Current Affairs In-depths & Editorials » GS2 » Society & Social Justice » Social Justice » Social Sector » Health » Diseases » ICMR Study Finds No Link Between COVID-19 Vaccines and Sudden Deaths

ICMR Study Finds No Link Between COVID-19 Vaccines and Sudden Deaths

Santhosh Kumar 23/11/2023

ICMR Study Finds No Link Between COVID-19 Vaccines and Sudden Deaths mind map
Reduction in Sudden Deaths Risk Post-Vaccination
Significant reduction among vaccinated individuals
Exoneration of Vaccines Amidst Apprehensions
Addresses concerns and reports linking deaths to vaccination
Provides reassurance against concerns
Impact of Severe COVID-19 on Sudden Death Risk
Severe COVID-19 increases risk of sudden deaths
Identification of Other Sudden Death Risk Factors
Family history of sudden death
Smoking, binge drinking
Vigorous intensity exercises
Consistency with Known Risk Factors
Aligns with established knowledge
Factors associated with sudden deaths
COVID-19’s Impact on Heart Health
Potentially contributes to heart disease and stroke
Attacks heart muscle cells and blood vessel linings
Comprehensive ICMR Studies on COVID-19
Emphasizes commitment to understanding COVID-19 impact
Investigates outcomes of COVID-19 hospitalizations
Studies clotting events following vaccination

If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.

Related Posts

India's TB Crisis: Nutritional Support and Policy Changes

India’s TB Crisis: Nutritional Support and Policy Changes

25/10/2024 / Diseases

Cervical Cancer in India mind map Recent News Special Push in Budget 2024 India's First Indigenous HPV Vaccine Name Cervavac Manufacturer Serum Institute of India Type Quadrivalent Cost ₹4,000 for two doses ₹2,000 per dose When Early Vaccination Optimal Age 9 to 14 years Why Prevention of Cervical Cancer What Symptoms Early Stages Often Asymptomatic Advanced Stages Unusual Vaginal Bleeding Foul-smelling Discharge Pelvic Pain HPV Vaccines Types Cervarix Bivalent Protects Against HPV Types 16, 18 Gardasil Quadrivalent Protects Against HPV Types 16, 18, 6, 11 Cost ₹3,957 per dose Cervavac Quadrivalent Made in India Screening Methods Importance in Prevention Treatment Services Accessibility Issues Where Urban and Rural India Urban Trends Breast Cancer More Common Rural Trends High Incidence of Cervical Cancer Who Key Figures Dr. Priya SP Patil Consultant Obstetrician and Gynaecologist Dr. Vigyan Mishra Chief of Lab-Neuberg Diagnostics Dr. Niti Raizada Senior Director, Medical Oncology, Fortis Hospitals How Vaccination Programs Government Initiatives Budget Allocation Public Health Centre Distribution Significance Preventable and Curable Disease Potential for Cervical Cancer Elimination Reduction in Other HPV-related Cancers Challenges High Vaccine Costs Accessibility in Rural Areas Social and Economic Constraints Way Forward Achieve 90% Vaccination by 2030 Increase Public Awareness Enhance Accessibility in Rural Areas

Cervical Cancer in India

02/02/2024 / Diseases

Cryptosporidium Parasite Found in UK Drinking Water

Cryptosporidium Parasite Found in UK Drinking Water

09/06/2024 / Diseases

India Receives Prestigious Measles and Rubella Champion Award mind map Recent News India bestowed with Measles and Rubella Champion Award By The Measles and Rubella Partnership On March 6, 2024 Award ceremony at American Red Cross Headquarters, Washington D.C., USA Ambassador Sripriya Ranganathan received the award Measles and Rubella Partnership Comprises American Red Cross BMGF GAVI US CDC UNF UNICEF WHO Significance of the award Celebrates India's commitment to public health Recognizes India's leadership in combating measles and rubella Acknowledges innovative strategies and effective public-awareness initiatives Highlights successful vaccination campaigns in high-risk areas 50 districts reported no measles cases 226 districts reported no rubella cases in the past 12 months Measles and Rubella in India Measles case reduction by 62% (2017-2021) Rubella case reduction by 48% (2017-2021) Over 348 million children vaccinated (2017-March 2023) MR Vaccine part of Universal Immunization Programme since 2017 Government aims for measles and rubella elimination Challenges and Way Forward Strengthening routine immunization under UIP Expanding MR Laboratory network Implementing Roadmap plan for MR Elimination Continuing proactive vaccination campaigns Maintaining robust surveillance systems Enhancing public awareness Collaboration with international partners essential for achieving elimination goals

India Receives Prestigious Measles and Rubella Champion Award

13/03/2024 / Diseases

Categories: Diseases

Tags: 23.11.2023, Newsbits

Subscribe

0 Comments

Inline Feedbacks

View all comments

X